Sanara MedTech Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Sanara MedTech Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue86.6764.9945.8424.1415.59
Cost of Revenue8.147.856.362.311.62
Gross Profit78.5357.1439.4821.8313.97
Operating Expenses
Research & Development5.704.133.370.560.04
Selling, General & Administrative76.5656.9945.9828.0518.67
Operating Expenses87.1961.3551.7129.2119.00
Operating Income-8.65-4.22-12.52-7.38-5.03
Other Income/Expense
Interest Income0.020.000.000.000.00
Interest Expense3.13-0.480.000.00-0.01
Other Income/Expense1.85-0.25-1.70-0.620.01
Income
Income Before Tax-9.91-7.89-13.94-7.99-4.45
Income Tax Expense0.00-0.67-5.840.050.00
Net Income-9.66-4.30-7.94-7.92-4.36
Net Income - Continuous Operations-9.91-4.44-8.09-7.990.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-1.86-0.96-11.57-7.40-4.74
EBIT-6.78-4.64-13.94-7.99-5.03
Depreciation & Amortization4.923.682.370.600.29
Earnings Per Share
Basic EPS-1.00-1.00-1.00-1.00-1.00
Diluted EPS-1.00-1.00-1.00-1.00-1.00
Basic Shares Outstanding8.488.287.917.345.73
Diluted Shares Outstanding8.488.287.917.345.73